Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1963 1
1964 2
1965 2
1967 3
1968 4
1969 1
1970 1
1971 1
1972 2
1973 5
1974 1
1975 2
1976 2
1977 3
1978 4
1979 17
1980 16
1981 18
1982 18
1983 21
1984 17
1985 13
1986 23
1987 25
1988 36
1989 25
1990 30
1991 30
1992 25
1993 38
1994 30
1995 26
1996 38
1997 39
1998 47
1999 37
2000 31
2001 36
2002 37
2003 43
2004 52
2005 56
2006 54
2007 55
2008 38
2009 56
2010 42
2011 48
2012 60
2013 56
2014 57
2015 61
2016 82
2017 71
2018 66
2019 79
2020 106
2021 97
2022 105
2023 91
2024 78

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,995 results

Results by year

Filters applied: . Clear all
Page 1
Microglial diversity in neuropathic pain.
Tsuda M, Masuda T, Kohno K. Tsuda M, et al. Trends Neurosci. 2023 Jul;46(7):597-610. doi: 10.1016/j.tins.2023.05.001. Epub 2023 May 25. Trends Neurosci. 2023. PMID: 37244781 Review.
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K. Tamura T, et al. Among authors: tsuda m. Nat Commun. 2023 May 16;14(1):2800. doi: 10.1038/s41467-023-38435-3. Nat Commun. 2023. PMID: 37193706 Free PMC article.
The liver-brain-gut neural arc maintains the Treg cell niche in the gut.
Teratani T, Mikami Y, Nakamoto N, Suzuki T, Harada Y, Okabayashi K, Hagihara Y, Taniki N, Kohno K, Shibata S, Miyamoto K, Ishigame H, Chu PS, Sujino T, Suda W, Hattori M, Matsui M, Okada T, Okano H, Inoue M, Yada T, Kitagawa Y, Yoshimura A, Tanida M, Tsuda M, Iwasaki Y, Kanai T. Teratani T, et al. Among authors: tsuda m. Nature. 2020 Sep;585(7826):591-596. doi: 10.1038/s41586-020-2425-3. Epub 2020 Jun 11. Nature. 2020. PMID: 32526765
Direct Comparison of Rotational vs Orbital Atherectomy for Calcified Lesions Guided by Optical Coherence Tomography.
Okamoto N, Egami Y, Nohara H, Kawanami S, Sugae H, Kawamura A, Ukita K, Matsuhiro Y, Nakamura H, Yasumoto K, Tsuda M, Matsunaga-Lee Y, Yano M, Nishino M, Tanouchi J. Okamoto N, et al. Among authors: tsuda m. JACC Cardiovasc Interv. 2023 Sep 11;16(17):2125-2136. doi: 10.1016/j.jcin.2023.06.016. JACC Cardiovasc Interv. 2023. PMID: 37704299 Free article. Clinical Trial.
Oxaliplatin-Associated Amaurosis Fugax.
Kubo K, Kimura N, Watanabe R, Higashino M, Tsuda M, Kato M. Kubo K, et al. Among authors: tsuda m. Case Rep Oncol. 2021 Jun 11;14(2):832-837. doi: 10.1159/000516271. eCollection 2021 May-Aug. Case Rep Oncol. 2021. PMID: 34248547 Free PMC article.
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Boku N, Ryu MH, Kato K, Chung HC, Minashi K, Lee KW, Cho H, Kang WK, Komatsu Y, Tsuda M, Yamaguchi K, Hara H, Fumita S, Azuma M, Chen LT, Kang YK. Boku N, et al. Among authors: tsuda m. Ann Oncol. 2019 Feb 1;30(2):250-258. doi: 10.1093/annonc/mdy540. Ann Oncol. 2019. PMID: 30566590 Free PMC article. Clinical Trial.
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5.
Tamura T, Yamasoba D, Oda Y, Ito J, Kamasaki T, Nao N, Hashimoto R, Fujioka Y, Suzuki R, Wang L, Ito H, Kashima Y, Kimura I, Kishimoto M, Tsuda M, Sawa H, Yoshimatsu K, Yamamoto Y, Nagamoto T, Kanamune J, Suzuki Y, Ohba Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Yokota I, Matsuno K, Takayama K, Tanaka S, Sato K, Fukuhara T. Tamura T, et al. Among authors: tsuda m. Commun Biol. 2023 Jul 24;6(1):772. doi: 10.1038/s42003-023-05081-w. Commun Biol. 2023. PMID: 37488344 Free PMC article.
1,995 results